Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for vTv Therapeutics (VTVT) over the last 11 years, with Q3 2025 value amounting to 0.56%.

  • vTv Therapeutics' Return on Capital Employed rose 600.0% to 0.56% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.56%, marking a year-over-year increase of 600.0%. This contributed to the annual value of 1.24% for FY2024, which is 9700.0% up from last year.
  • As of Q3 2025, vTv Therapeutics' Return on Capital Employed stood at 0.56%, which was up 600.0% from 1.07% recorded in Q2 2025.
  • In the past 5 years, vTv Therapeutics' Return on Capital Employed ranged from a high of 0.41% in Q3 2021 and a low of 10.84% during Q4 2023
  • Moreover, its 5-year median value for Return on Capital Employed was 0.95% (2022), whereas its average is 1.61%.
  • Examining YoY changes over the last 5 years, vTv Therapeutics' Return on Capital Employed showed a top increase of 366800bps in 2021 and a maximum decrease of -101200bps in 2021.
  • Quarter analysis of 5 years shows vTv Therapeutics' Return on Capital Employed stood at 1.09% in 2021, then rose by 22bps to 0.85% in 2022, then tumbled by -1183bps to 10.84% in 2023, then skyrocketed by 94bps to 0.68% in 2024, then rose by 17bps to 0.56% in 2025.
  • Its Return on Capital Employed stands at 0.56% for Q3 2025, versus 1.07% for Q2 2025 and 0.81% for Q1 2025.